Medicine
Heparin 10000 units/mL injection
Heparin 10000 units/mL injection is a generic prescription medicine for intravenous, subcutaneous use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Heparin
- Brand
- Sold under the generic name
- Strength
- 10000 units/mL
- Dosage form
- Injection
- Route
- Intravenous, subcutaneous
- Packs
- 24 blister pack, 25 vials, 50 cartridges and 24 more
- Manufacturers
- Fresenius KabiHealthFirstMeitheal PharmaceuticalsSagent PharmaceuticalsCardinal HealthHepalinkHospiraSandozBE PharmaceuticalsHikma Pharmaceuticals13 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AB01 Heparin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 February 1972
- Identifiers
- RxCUI 1361226, 1361574, 1361615 +7DailyMed set ID c4c6bc1f-e0c7-fd0d-e053-2995a90abdef, 02fb700d-a28c-4d45-b78d-382dc0d5986c, 1c634e53-44d6-cdcd-e063-6294a90a92e9 +18NDC 81952-113, 71288-451, 0781-3439 +21Application ANDA203198, ANDA211007, NDA017029 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 24 blister pack in 1 carton / 1 syringe in 1 blister pack / .5 mL in 1 syringe | 63323-118-05 | Fresenius Kabi | 16 November 2018 |
| 25 vial in 1 tray / 1 mL in 1 vial | 63323-542-13 | Fresenius Kabi | 4 November 2019 |
| 25 vial in 1 tray / 5 mL in 1 vial | 63323-542-14 | Fresenius Kabi | 4 November 2019 |
| 25 vial in 1 tray / .5 mL in 1 vial | 63323-543-13 | Fresenius Kabi | 4 November 2019 |
| 25 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 71288-404-02 | Meitheal Pharmaceuticals | 15 June 2019 |
| 25 vial, multi-dose in 1 carton / 4 mL in 1 vial, multi-dose | 71288-404-05 | Meitheal Pharmaceuticals | 15 June 2019 |
| 24 blister pack in 1 carton / 1 syringe, glass in 1 blister pack / .5 mL in 1 syringe, glass | 71288-405-81 | Meitheal Pharmaceuticals | 2 April 2020 |
| 25 vial, multi-dose in 1 carton / 1 mL in 1 vial, multi-dose | 71288-451-02 | Meitheal Pharmaceuticals | 2 July 2025 |
| 50 cartridge in 1 container / .5 mL in 1 cartridge | 0409-1316-32 | Hospira | 31 March 2005 |
| 25 vial, single-dose in 1 tray / 1 mL in 1 vial, single-dose | 0409-2721-01 | Hospira | 31 August 2009 |
| 25 vial in 1 carton / 1 mL in 1 vial | 25021-403-01 | Sagent Pharmaceuticals | 6 July 2010 |
| 25 vial in 1 carton / 4 mL in 1 vial | 25021-403-04 | Sagent Pharmaceuticals | 6 July 2010 |
| 25 vial in 1 carton / 1 mL in 1 vial | 25021-403-66 | Sagent Pharmaceticals | 1 July 2014 |
| 25 vial, multi-dose in 1 carton / 1 mL in 1 vial, multi-dose | 0781-3439-25 | Sandoz | 16 September 2024 |
| 25 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose | 0781-3533-25 | Sandoz | 16 September 2024 |
| 25 vial, single-dose in 1 carton / .5 mL in 1 vial, single-dose | 71839-118-25 | BE Pharmaceuticals | 29 December 2020 |
| 25 vial, multi-dose in 1 carton / 1 mL in 1 vial, multi-dose | 81952-113-06 | Hepalink | 12 June 2014 |
| 25 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose | 81952-113-08 | Hepalink | 12 June 2014 |
| 25 vial in 1 package / 1 mL in 1 vial | 0641-0410-12 | Hikma Pharmaceuticals | 22 March 1972 |
| 5 mL in 1 vial | 51662-1409-1 | HealthFirst | 11 November 2019 |
| 25 pouch in 1 case / 1 vial in 1 pouch / 5 mL in 1 vial | 51662-1409-3 | HealthFirst | 10 November 2022 |
| 1 mL in 1 vial, multi-dose | 51662-1434-1 | HealthFirst | 10 January 2020 |
| 1 mL in 1 vial, single-dose | 51662-1486-1 | HealthFirst | 9 March 2020 |
| 5 cartridge in 1 bag / .5 mL in 1 cartridge | 55154-2380-5 | Cardinal Health | 7 December 2009 |
| 5 vial in 1 bag / .5 mL in 1 vial | 55154-9589-5 | Cardinal Health | 12 May 2026 |
| 25 vial, multi-dose in 1 carton / 1 mL in 1 vial, multi-dose | 72603-579-25 | Northstar Rx | 1 March 2025 |
| 25 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 72603-501-25 | NorthStar RxLLC | 1 April 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 9 February 1939 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Heparin
Clinical summary
Heparin is an anti-coagulant indicated for prophylaxis and treatment of venous thrombosis and pulmonary embolism,, among other approved uses. It is available as injection for intravenous and subcutaneous use. MedsAcross supplies Heparin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about HeparinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Heparin Sodium prescribing information (Fresenius Kabi) · U.S. National Library of Medicine, DailyMed
Need Heparin 10000 units/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.